Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 180 mg
Pharmacor Pty Ltd
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; macrogol 6000; hypromellose; croscarmellose sodium; mannitol; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red
Oral
70, 10,30,50,100
(S2) Pharmacy Medicine
Relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older.
Visual Identification: Peach coloured, caplet shaped, debossed as '180' on one side and plain on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2013-04-18